本页面由Tiger Trade Technology Pte. Ltd.提供服务

Cogent Biosciences, Inc.

29.78
-1.2200-3.94%
盘后:29.780.00000.00%19:30 EDT
成交量:185.53万
成交额:5,605.66万
市值:51.68亿
市盈率:-13.79
高:31.07
开:30.81
低:29.63
收:31.00
52周最高:43.73
52周最低:13.78
股本:1.74亿
流通股本:1.67亿
量比:0.80
换手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-2.1600
每股收益(LYR):-2.5504
净资产收益率:-109.74%
总资产收益率:-43.84%
市净率:11.05
市盈率(LYR):-11.68

数据加载中...

2023/06/14

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/08

重要事件披露

Form 8-K - Current report
2023/06/06

重要事件披露

Form 8-K - Current report
2023/06/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/14

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/14

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/14

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/12

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report